Similar Articles
991 Does herbal medicine reduce the risk of hepatocellular carcinoma?
992 Potentiality of immunotherapy against hepatocellular carcinoma
993 Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
994 Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
995 Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice
996 Liver resection for hepatocellular carcinoma using a microwave tissue coagulator: Experience of 1118 cases
997 Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation
998 Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients
999 Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature
1000 Mechanism of QHF-cisplatin against hepatocellular carcinoma in a mouse model
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA